BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31349905)

  • 1. Clinical and translational advances in esophageal squamous cell carcinoma.
    Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA
    Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sparse Representation-Based Patient-Specific Diagnosis and Treatment for Esophageal Squamous Cell Carcinoma.
    Huang B; Zhong N; Xia L; Yu G; Cao H
    Bull Math Biol; 2018 Aug; 80(8):2124-2136. PubMed ID: 29869044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions.
    Wang M; Smith JS; Wei WQ
    Ann N Y Acad Sci; 2018 Dec; 1434(1):59-69. PubMed ID: 29882970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
    Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
    Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.
    Talukdar FR; di Pietro M; Secrier M; Moehler M; Goepfert K; Lima SSC; Pinto LFR; Hendricks D; Parker MI; Herceg Z
    Ann N Y Acad Sci; 2018 Dec; 1434(1):342-359. PubMed ID: 29917250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy as a cytoprotective mechanism in esophageal squamous cell carcinoma.
    Hall TM; Tétreault MP; Hamilton KE; Whelan KA
    Curr Opin Pharmacol; 2018 Aug; 41():12-19. PubMed ID: 29677645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in treating oesophageal cancer.
    Harada K; Rogers JE; Iwatsuki M; Yamashita K; Baba H; Ajani JA
    F1000Res; 2020; 9():. PubMed ID: 33042518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cells in esophageal cancer and response to therapy.
    Harada K; Pool Pizzi M; Baba H; Shanbhag ND; Song S; Ajani JA
    Cancer; 2018 Oct; 124(20):3962-3964. PubMed ID: 30368777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verrucous esophageal carcinoma is a unique indolent subtype of squamous cell carcinoma: a systematic review and individual patient regression analysis.
    Li DK; Haffar S; Horibe M; Homsi HA; Zukerberg L; Murad MH; Visrodia KH; Gala M; Katzka DA; Bazerbachi F
    J Gastroenterol; 2021 Jan; 56(1):12-24. PubMed ID: 33079233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalized and targeted therapy of esophageal squamous cell carcinoma: an update.
    Liu Y; Xiong Z; Beasley A; D'Amico T; Chen XL
    Ann N Y Acad Sci; 2016 Oct; 1381(1):66-73. PubMed ID: 27399176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
    Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
    Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
    Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
    Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of chemotherapeutics for unresectable advanced esophageal cancer.
    Imazeki H; Kato K
    Expert Rev Anticancer Ther; 2020 Dec; 20(12):1083-1092. PubMed ID: 32820965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous Cell Carcinoma of the Esophagus.
    Codipilly DC; Wang KK
    Gastroenterol Clin North Am; 2022 Sep; 51(3):457-484. PubMed ID: 36153105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma.
    Ohashi S; Miyamoto S; Kikuchi O; Goto T; Amanuma Y; Muto M
    Gastroenterology; 2015 Dec; 149(7):1700-15. PubMed ID: 26376349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to Localized Squamous Cell Cancer of the Esophagus.
    Weidenbaum C; Gibson MK
    Curr Treat Options Oncol; 2022 Oct; 23(10):1370-1387. PubMed ID: 36042147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
    Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
    World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
    Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
    Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.